Profile data is unavailable for this security.
About the company
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
- Revenue in INR (TTM)58.49bn
- Net income in INR12.01bn
- Incorporated1944
- Employees3.70k
- LocationAbbott India Ltd3-4 Corporate ParkSion-Trombay Road, ChemburMUMBAI 400051IndiaIND
- Phone+91 2 250461000
- Fax+91 2 267978727
- Websitehttps://www.abbott.co.in/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rainbow Children's Medicare Ltd | 12.97bn | 2.17bn | 132.96bn | 3.58k | 61.27 | 10.56 | 40.25 | 10.25 | 21.38 | 21.38 | 127.78 | 124.03 | 0.6581 | 7.73 | 21.29 | -- | 11.08 | 9.89 | 11.99 | 10.96 | 87.26 | 83.51 | 16.83 | 13.80 | 4.00 | 5.36 | 0.377 | -- | 10.51 | 19.03 | 2.93 | 37.23 | 32.22 | -- |
| Krishna Institute Of Medical Sciencs Ltd | 24.98bn | 3.10bn | 162.99bn | 10.00k | 52.55 | 8.91 | 33.77 | 6.52 | 38.76 | 38.76 | 312.20 | 228.46 | 0.7355 | 11.49 | 9.13 | -- | 9.90 | 13.71 | 12.20 | 16.73 | 78.77 | 61.42 | 13.46 | 15.53 | 1.10 | 10.44 | 0.393 | -- | 13.67 | 22.17 | -7.78 | -- | 52.94 | -- |
| Aster DM Healthcare Ltd | 84.60bn | 293.50m | 178.25bn | 24.65k | 609.61 | 3.91 | 28.74 | 2.11 | 0.5874 | 2.60 | 170.48 | 91.60 | 0.5147 | 4.81 | 6.58 | -- | 0.6792 | 2.24 | 1.39 | 3.60 | 59.78 | 60.17 | 1.32 | 4.26 | 1.25 | 1.87 | 0.2157 | -- | 23.54 | -14.22 | 12.28 | -18.15 | 6.87 | -- |
| Dr. Lal PathLabs Ltd | 22.27bn | 3.58bn | 228.86bn | 4.10k | 63.99 | 12.38 | 45.24 | 10.28 | 42.98 | 42.98 | 267.51 | 222.23 | 0.9198 | 12.70 | 30.04 | 5,432,157.00 | 14.97 | 15.49 | 18.88 | 19.38 | 79.73 | 76.13 | 16.27 | 15.99 | 2.34 | 15.86 | 0.1158 | 23.86 | 10.40 | 13.10 | 49.78 | 12.43 | 6.44 | 31.95 |
| Narayana Hrudayalaya Ltd | 50.22bn | 7.89bn | 251.30bn | 11.73k | 31.83 | 8.71 | 24.36 | 5.00 | 38.87 | 38.87 | 247.31 | 141.98 | 1.03 | 21.58 | 11.77 | -- | 16.14 | 10.79 | 20.55 | 13.97 | 61.00 | 49.83 | 15.72 | 9.72 | 1.65 | 9.39 | 0.3605 | -- | 10.91 | 11.89 | 30.19 | 67.89 | 45.27 | 31.95 |
| Fortis Healthcare Ltd | 68.93bn | 5.99bn | 379.18bn | 2.98k | 63.34 | 4.95 | 38.39 | 5.50 | 7.93 | 7.93 | 91.26 | 101.50 | 0.536 | 14.06 | 11.40 | -- | 5.02 | 3.54 | 6.66 | 4.57 | 76.52 | 73.87 | 9.36 | 7.63 | 0.4142 | 7.62 | 0.1189 | -- | 9.45 | 9.05 | 1.72 | -- | 62.52 | -- |
| Abbott India Ltd | 58.49bn | 12.01bn | 583.61bn | 3.70k | 48.59 | 15.78 | 45.87 | 9.98 | 565.28 | 565.28 | 2,752.43 | 1,740.71 | 1.20 | 5.08 | 18.39 | -- | 24.64 | 20.92 | 33.37 | 28.59 | 44.94 | 44.32 | 20.54 | 17.26 | 1.96 | 111.00 | 0.022 | 48.29 | 9.35 | 9.72 | 26.52 | 21.68 | 31.08 | 52.32 |
| Apollo Hospitals Enterprise Limited | 190.59bn | 8.99bn | 892.56bn | 83.15k | 99.32 | 12.87 | 55.03 | 4.68 | 62.50 | 62.50 | 1,325.64 | 482.35 | 1.22 | 23.07 | 7.56 | -- | 6.00 | 5.51 | 8.32 | 7.16 | 48.55 | 48.52 | 4.91 | 4.84 | 1.03 | 3.95 | 0.4215 | 21.94 | 14.73 | 14.66 | 9.71 | 30.65 | -- | 21.67 |
| Max Healthcare Institute Ltd | 54.06bn | 10.58bn | 901.84bn | 3.73k | 85.44 | 10.73 | 69.24 | 16.68 | 10.86 | 10.86 | 55.51 | 86.51 | 0.4892 | 14.33 | 13.54 | -- | 9.57 | 6.98 | 10.68 | 8.06 | 79.31 | 77.19 | 19.56 | 15.02 | 1.30 | 20.82 | 0.1338 | -- | 18.49 | 26.17 | -4.16 | -- | 46.42 | -- |
| Holder | Shares | % Held |
|---|---|---|
| SBI Funds Management Ltd.as of 31 May 2024 | 442.09k | 2.08% |
| Canara Robeco Asset Management Co. Ltd.as of 31 May 2024 | 307.61k | 1.45% |
| Axis Asset Management Co. Ltd.as of 31 May 2024 | 171.03k | 0.81% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 May 2024 | 151.47k | 0.71% |
| PGIM India Asset Management Pvt Ltd.as of 31 May 2024 | 66.36k | 0.31% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 31 May 2024 | 57.02k | 0.27% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 May 2024 | 54.93k | 0.26% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 31 May 2024 | 52.30k | 0.25% |
| Bandhan Asset Management Co. Ltd.as of 31 May 2024 | 37.13k | 0.18% |
| Kotak Mahindra Asset Management Co. Ltd.as of 31 May 2024 | 31.56k | 0.15% |
